In Depth 30 Oct 2024 Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies. October 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 21 Oct 2024 Turning back time with cellular reprogramming: Shift raises $16 million in seed funding As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases. October 21, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2024 Spinal cord injury: Are we getting closer to a treatment? Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition. October 7, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2024 Resolution Therapeutics raises $85 million to advance its macrophage therapy Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round. October 3, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 26 Jul 2024The first mass-market cell therapy? Listen to our conversation with CEO Greg Kunst about how Aurion’s treatment could be the first mass-market cell therapy available July 26, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Cryoport Systems 18 Jun 2024 Overcoming obstacles as advanced therapies continue to evolve in Europe Discover strategies to overcome the challenges in advanced therapy development in Europe’s evolving biopharmaceutical landscape. June 18, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Jun 2024 Eight companies tackling cancer with allogeneic cell therapy in 2024 Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […] June 13, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 31 May 2024Can cell therapy tackle hearing loss Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss. May 31, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Lumicks 14 May 2024 Cell avidity-tuning ensures safe CAR-T therapy for solid tumors Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors. May 14, 2024 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 29 Apr 2024 Can Brazil make cell and gene therapy costs affordable for all? Found out how Brazil is attempting to make gene and cell therapy costs affordable for all with a new initiative. April 29, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Mar 2024 Are these T cell receptor (TCR) therapy companies on your radar? As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic. March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Mar 2024 The 9 hottest private biotech companies in San Diego Discover nine visionary biotech companies headquartered in San Diego, which is one of the biggest biotech hubs in the US. March 19, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email